Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring (Jan 2021)
Impairment of episodic memory in genetic frontotemporal dementia: A GENFI study
- Jackie M. Poos,
- Lucy L. Russell,
- Georgia Peakman,
- Martina Bocchetta,
- Caroline V. Greaves,
- Lize C. Jiskoot,
- Emma L. van derEnde,
- Harro Seelaar,
- Janne M. Papma,
- Esther vanden Berg,
- Yolande A.L. Pijnenburg,
- Barbara Borroni,
- Raquel Sanchez‐Valle,
- Fermin Moreno,
- Robert Laforce,
- Caroline Graff,
- Matthias Synofzik,
- Daniela Galimberti,
- James B. Rowe,
- Mario Masellis,
- Carmela Tartaglia,
- Elizabeth Finger,
- Rik Vandenberghe,
- Alexandre deMedonça,
- Fabrizio Tagliavini,
- Chris R. Butler,
- Isabel Santana,
- Isabelle Le Ber,
- Alex Gerhard,
- Simon Ducharme,
- Johannes Levin,
- Adrian Danek,
- Markus Otto,
- Sandro Sorbi,
- Florence Pasquier,
- John C. vanSwieten,
- Jonathan D. Rohrer,
- the Genetic FTD Initiative, GENFI
Affiliations
- Jackie M. Poos
- Department of Neurology Erasmus Medical Center Rotterdam the Netherlands
- Lucy L. Russell
- Dementia Research Centre Department of Neurodegenerative Disease UCL Queen Square Institute of Neurology London UK
- Georgia Peakman
- Dementia Research Centre Department of Neurodegenerative Disease UCL Queen Square Institute of Neurology London UK
- Martina Bocchetta
- Dementia Research Centre Department of Neurodegenerative Disease UCL Queen Square Institute of Neurology London UK
- Caroline V. Greaves
- Dementia Research Centre Department of Neurodegenerative Disease UCL Queen Square Institute of Neurology London UK
- Lize C. Jiskoot
- Department of Neurology Erasmus Medical Center Rotterdam the Netherlands
- Emma L. van derEnde
- Department of Neurology Erasmus Medical Center Rotterdam the Netherlands
- Harro Seelaar
- Department of Neurology Erasmus Medical Center Rotterdam the Netherlands
- Janne M. Papma
- Department of Neurology Erasmus Medical Center Rotterdam the Netherlands
- Esther vanden Berg
- Department of Neurology Erasmus Medical Center Rotterdam the Netherlands
- Yolande A.L. Pijnenburg
- Department of Neurology Alzheimer Center Location VU University Medical Center Amsterdam Amsterdam the Netherlands
- Barbara Borroni
- Centre for Neurodegenerative Disorders Department of Clinical and Experimental Sciences University of Brescia Brescia Italy
- Raquel Sanchez‐Valle
- Alzheimer's Disease and Other Cognitive Disorders Unit Neurology Service Hospital Clínic Institut d'Investigacións Biomèdiques August Pi I Sunyer University of Barcelona Barcelona Spain
- Fermin Moreno
- Cognitive Disorders Unit Department of Neurology Donostia University Hospital San Sebastian Gipuzkoa Spain
- Robert Laforce
- Clinique Interdisciplinaire de Mémoire Département des Sciences Neurologiques CHU de Québec Faculté de Médecine Université Laval Quebec Canada
- Caroline Graff
- Center for Alzheimer Research, Division of Neurogeriatrics Department of Neurobiology, Care Sciences and Society Bioclinicum Karolinska Institutet Solna Sweden
- Matthias Synofzik
- Department of Neurodegenerative Diseases Hertie‐Institute for Clinical Brain Research and Center of Neurology University of Tübingen Tübingen Germany
- Daniela Galimberti
- Department of Biomedical, Surgical and Dental Sciences University of Milan Milan Italy
- James B. Rowe
- Department of Clinical Neurosciences Cambridge University Hospitals NHS Trust Medical Research Council Cognition and Brain Sciences Unit University of Cambridge Cambridge UK
- Mario Masellis
- Sunnybrook Health Sciences Centre Sunnybrook Research Institute University of Toronto Toronto Canada
- Carmela Tartaglia
- Tanz Centre for Research in Neurodegenerative Diseases University of Toronto Toronto Canada
- Elizabeth Finger
- Department of Clinical Neurological Sciences University of Western Ontario London Canada
- Rik Vandenberghe
- Laboratory for Cognitive Neurology Department of Neurosciences KU Leuven Leuven Belgium
- Alexandre deMedonça
- Laboratory of Neurosciences Institute of Molecular Medicine Faculty of Medicine University of Lisbon Lisbon Portugal
- Fabrizio Tagliavini
- Fondazione IRCCS Istituto Neurologico Carlo Besta Milan Italy
- Chris R. Butler
- Nuffield Department of Clinical Neurosciences Medical Sciences Division University of Oxford Oxford UK
- Isabel Santana
- University Hospital of Coimbra (HUC) Neurology Service Faculty of Medicine University of Coimbra Coimbra Portugal
- Isabelle Le Ber
- Sorbonne Université Institut du Cerveau (ICM) INSERM U1127 CNRS UMR 7225 APHP Hôpital Pitié‐Salpêtrière Paris France
- Alex Gerhard
- Division of Neuroscience and Experimental Psychology Wolfson Molecular Imaging Centre University of Manchester, Manchester UK
- Simon Ducharme
- Douglas Mental Health University Institute Department of Psychiatry McGill University Montreal Canada
- Johannes Levin
- Neurologische Klinik und Poliklinik Ludwig‐Maximilians‐Universität Munich Germany
- Adrian Danek
- Neurologische Klinik und Poliklinik Ludwig‐Maximilians‐Universität Munich Germany
- Markus Otto
- Department of Neurology University of Ulm Ulm Germany
- Sandro Sorbi
- Department of Neurofarba University of Florence Firenze Italy
- Florence Pasquier
- University of Lille Lille France
- John C. vanSwieten
- Department of Neurology Erasmus Medical Center Rotterdam the Netherlands
- Jonathan D. Rohrer
- Dementia Research Centre Department of Neurodegenerative Disease UCL Queen Square Institute of Neurology London UK
- the Genetic FTD Initiative, GENFI
- Department of Neurology Erasmus Medical Center Rotterdam the Netherlands
- DOI
- https://doi.org/10.1002/dad2.12185
- Journal volume & issue
-
Vol. 13,
no. 1
pp. n/a – n/a
Abstract
Abstract Introduction We aimed to assess episodic memory in genetic frontotemporal dementia (FTD) with the Free and Cued Selective Reminding Test (FCSRT). Methods The FCSRT was administered in 417 presymptomatic and symptomatic mutation carriers (181 chromosome 9 open reading frame 72 [C9orf72], 163 progranulin [GRN], and 73 microtubule‐associated protein tau [MAPT]) and 290 controls. Group differences and correlations with other neuropsychological tests were examined. We performed voxel‐based morphometry to investigate the underlying neural substrates of the FCSRT. Results All symptomatic mutation carrier groups and presymptomatic MAPT mutation carriers performed significantly worse on all FCSRT scores compared to controls. In the presymptomatic C9orf72 group, deficits were found on all scores except for the delayed total recall task, while no deficits were found in presymptomatic GRN mutation carriers. Performance on the FCSRT correlated with executive function, particularly in C9orf72 mutation carriers, but also with memory and naming tasks in the MAPT group. FCSRT performance also correlated with gray matter volumes of frontal, temporal, and subcortical regions in C9orf72 and GRN, but mainly temporal areas in MAPT mutation carriers. Discussion The FCSRT detects presymptomatic deficits in C9orf72‐ and MAPT‐associated FTD and provides important insight into the underlying cause of memory impairment in different forms of FTD.
Keywords